Indies Pharma Jamaica Balance Sheet Health
Financial Health criteria checks 2/6
Indies Pharma Jamaica has a total shareholder equity of JMD1.4B and total debt of JMD817.4M, which brings its debt-to-equity ratio to 60.4%. Its total assets and total liabilities are JMD2.3B and JMD997.1M respectively. Indies Pharma Jamaica's EBIT is JMD327.2M making its interest coverage ratio 5.4. It has cash and short-term investments of JMD234.6M.
Key information
60.4%
Debt to equity ratio
JA$817.35m
Debt
| Interest coverage ratio | 5.4x |
| Cash | JA$234.62m |
| Equity | JA$1.35b |
| Total liabilities | JA$997.14m |
| Total assets | JA$2.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INDIES's short term assets (JMD829.8M) exceed its short term liabilities (JMD111.6M).
Long Term Liabilities: INDIES's short term assets (JMD829.8M) do not cover its long term liabilities (JMD885.5M).
Debt to Equity History and Analysis
Debt Level: INDIES's net debt to equity ratio (43.1%) is considered high.
Reducing Debt: INDIES's debt to equity ratio has increased from 0% to 60.4% over the past 5 years.
Debt Coverage: INDIES's debt is not well covered by operating cash flow (15.9%).
Interest Coverage: INDIES's interest payments on its debt are well covered by EBIT (5.4x coverage).